miR‑6852 serves as a prognostic biomarker in colorectal cancer and inhibits tumor growth and metastasis by targeting TCF7Baohong Cui(Third Affiliated Hospital of Harbin Medical University), Xuan Hong(Harbin Medical University)Experimental and Therapeutic MedicineJune 7, 201810.3892/etm.2018.6259Cited by 17SaveCiteExport RISWatch citationsRelated PapersTargeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer|Cancer Cell|2018|71